Kusama H, Horimoto Y, Takabe K, Ishikawa T. Should All Low-Grade Ductal Carcinoma In Situ Be Excised? Implications and Challenges of the COMET Trial. World J Oncol. 2025;16(2):239-241. doi:10.14740/wjon2562